Differential (Click to cross reference) adverse drug reaction cardiovascular disease central retinal artery occlusion cerebrovascular accident cerebrovascular accident, prevention of cerebrovascular accident, primary prevention complications compression neuropathy diabetes mellitus diabetes mellitus, neurologic manifestations of glucagon-like peptide-1 hemoglobin A1c iatrogenic neurologic disorders intracranial hypertension, benign intracranial pressure, increased leg weakness, unilateral lumbosacral radiculoplexopathy microvasculitis neuropathy neuropathy, diabetic neuropathy, iatrogenic neuropathy, vasculitic, nonsystemic obesity pain, leg patient information and support peroneal nerve palsy peroneal nerve, lesion of practice guidelines prevention of neurologic disorders review article semaglutide sleep apnea, obstructive small vessel vasculitis tirzepatide treatment induced neuropathy of diabetes treatment of neurologic disorder vasculitides weight loss weight management

Showing articles 0 to 6 of 6 Central Retinal Artery Occlusion with Cilioretinal Artery Sparing after Semaglutide Injection JAMA Neurol 82:416-417, Shabto,J.M.,et al, 2025 Use and Eligibility for Glucose-Like Peptide-1 Receptor Agonist Treatment for Primary Preveention of Stroke Neurol 104:e213739, Wilson,L.M. & Anderson,T.S., 2025 GLP-1RA-Associated Diabetic Lumbosacral Radiculoplexus and Common Fibular Neuropathies Neurol 105:e213916, Triplett,J.D.,et al, 2025 GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension JAMA Neurol 82:887-892, Sioutas,G.S.,et al, 2025 The Role of GLP-1 (Glucagon-Like Peptide-1) Receptor Agonists in Primary Stroke Prevention Stroke 56:e307-e309, Inikori,E.,et al, 2025 Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity NEJM 391:1193-1205, Malhotra,A.,et al, 2024 Showing articles 0 to 6 of 6